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Abstract
Background: Cystosarcoma phylloides (CP) is an extremely rare form of breast cancer with an
unpredictable clinical course. The histological characteristics of this neoplasm have not proved to
offer much in the estimation of prognosis of these patients.
Patients and methods: In our clinics, in a time period of 38 years, 22 patients with cystosarcoma
phylloides were treated. There were 5 cases of malignancy, 15 cases with benign tumors, and two
cases histologically characterized  a s b o rd e r l i ne  n e op l as i a .  M e t a s t as e s  w e r e  m a n i f e s t e d  i n  on e
patient. All patients were on a 5-year follow-up, except in five cases, one operated three years ago
and four operated within the last two years.
Results: 16 of 22 patients did not present any signs of local recurrence or metastases. There were
three patients that manifested local recurrence and underwent supplementary ongectomy or
mastectomy and are free of recurrence ever since. One patient with metastatic CP died.
Conclusion: Independently of its histopathological behavior, CP is a tumor difficult to be treated.
Meticulous follow-up is mandatory in order to manage possible recurrence of the neoplasm.
Background
Cysteosarcoma phylloides (CP) constitutes a rare form of
breast neoplasia, which represents less than 1% of total
breast neoplasias and only 2,3% of all fibro-epithelial
breast tumors [1-4]. It was first described by Muller in
1838, who also introduced the term "cystosarcoma phyl-
loides" because of the extensions of the tumor mimicking
the shape of leaves, intruding within the cystic cavities of
the tumor [5]. This neoplasm is manifested in women of
all ages, including adolescent and the elderly, with the
majority ranging between 35 and 54 years [6-10]. Multi-
ple studies have been conducted during the recent years
concerning the comprehension of the biological behavior
of CP [11,12]. The histological classification of these neo-
plasms into benign, malignant and borderline has not
proven to be successful, because the benign form of cys-
tosarcoma phylloides could manifest metastases, while
cases with malignant type of CP finally presented an excel-
lent prognosis [13-15].
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Presentation of our experience
In the time period between 1968 and 2007, 22 women of
a mean age of 38 years, presented in our clinics with the
diagnosis of cystosarcoma phylloides. Among them 19
were operated for breast tumor, which was proved by the
histological examination to be a cystosarcoma phylloides.
The remaining three were previously treated in other insti-
tutions and were referred to our hospital for further treat-
ment.
The main complaint among these women was a palpable,
painless mass of the breast. Two patients presented pain
of the breast region, while one patient mentioned tender-
ness of the respective axilla. In 11 patients the mass was
located on the right breast, while in the remaining 11
patients it was found in the left breast. The clinical exam-
ination revealed a solitary mobile tumoral lesion in all the
patients, measuring between 3–12 cm. Three patients pre-
sented with dilated veins of the overlying skin and in one
case bluish discoloration of the skin of the breast above
the tumor was present. A palpable mass of the respective
auxiliary region was observed in two women.
The initial management was surgical in 21 of 22 cases,
including tumor resection within healthy borders in 12
patients and simple mastectomy in 5 cases. The two
patients with enlarged lymph glands were treated by mod-
ified radical mastectomy, and there were two cases where
subcutaneous mastectomy and silicone prostheses inser-
tion was performed. Among them, there was a woman
who presented at our clinic with the diagnosis of benign
cysteosarcoma phylloides, from a recent breast biopsy
performed elsewhere, who underwent wide local excision
of the remaining tumor. This patient had two local exci-
sions of a benign cytosarcoma phylloides eight and four
years previously. There was also one patient who mani-
fested local recurrence of benign CP, having undergone
simple mastectomy six months before at another institu-
tion. The remaining patient had undergone a previous
simple mastectomy three years ago for the management of
malignant CP and did not present any signs of local recur-
rence, but only clinical signs of pulmonary and pleural
metastasis.
Results
Histological examination of the resected breast segment
revealed a benign lesion in 15 cases, a malignant tumor in
4 cases, while in the remaining two cases the neoplasm
was characterized as borderline. The enlarged lymph
nodes resected in two patients were established by the
pathologoanatomic examination as presenting signs of
reactive hyperplasia, and no metastatic element was iden-
tified in them.
The woman who presented with pulmonary and pleural
metastasis, established by clinical examination and labo-
ratory control (chest X-rays, pleural aspiration and cyto-
logical examination) died three months after the
diagnosis.
All the remaining patients were followed-up for 5 years for
signs of recurrence. One of the patients with a CP charac-
terized as borderline manifested local recurrence two
years after initial ongectomy. She was managed by wide
total excision of the tumor, though she came back two
years after the second operation with signs of a new recur-
rence. She refused to undergo a third operation for
esthetic reasons and was lost on follow-up. Another
woman appeared four years after primary surgical treat-
ment with a locally recurred lesion; a wide local excision
was performed. However, the histological examination
demonstrated that the tumor was a fibroadenoma, thus
this case was not considered as a recurrent CP. The
remaining women did not manifest any signs of recur-
rence during follow-up. The last five patients who were
treated in our institution for cystosarcoma fylloides were
operated one of them three years ago, two of them one
year ago and the remaining two were treated within the
year 2007, so they have not yet completed the 5-year fol-
low-up; until today all five are free of recurrence symp-
toms and signs.
Figure 1 demonstrates the clinical course of all 22 patients
treated in our hospital, since the disease first appeared.
Discussion
Cystosarcoma phylloides is a rare breast tumor, which
presents a rapid development among young women. It
usually takes over a quarter or half of the affected breast.
On palpation it is mobile with clear borders. Due to the
big size of the tumor, the overlying skin is tense, and
presents a visible and dilated venous plexus. As a result,
skin ulceration may easily be created. Enlargement of the
auxiliary lymph nodes is a rare symptom. These tumors
are most commonly benign and only 10% of them
present a malignant behavior. They do not manifest breast
fascia infiltration, though they invade in adjacent tissues.
At a rate of 50% these neoplasms give metastasis to the
bones and viscera, mainly heamatogenously [16].
Another common characteristic seems to be their fre-
quently observed local recurrences, independently of
malignancy [17].
Laboratory control, such as ultrasonography, mammogra-
phy, etc., in combination with the clinical examination
and the self-examination will definitely lead to the recog-
nition of a lesion variably sized. Small tumors may be
characterized as fibroadenomas [18], while larger ones
look like sarcomas of undefined appearance, create ten-International Seminars in Surgical Oncology 2009, 6:6 http://www.issoonline.com/content/6/1/6
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sion on the skin and may present regions of superficial
hemorrhage or necrosis. The prognostic value of immuno-
histochemical indexes for the cystosarcoma phylloides
provides very little to a definitive prognosis. This is due to
the small number of studies upon this subject, as well as
the variety of histological classifications for CP [19-21].
Through the years, all types of breast surgery have been
used for the management of cystosarcoma phylloides.
Radical mastectomy is no longer applied, and because the
tumor is heamatogenously disseminated, resection of
auxiliary lymph nodes is not justified [20,22]. Nowadays,
Clinical course of 22 patients with cysteosarcoma phylloides Figure 1
Clinical course of 22 patients with cysteosarcoma phylloides.
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the preferred procedure is local resection of the tumor
within healthy borders (1–2 cm) in order to prevent local
recurrence [12,23]. A total mastectomy is performed if
necessary, such as in cases of large tumors, which occupy
the whole breast [23-25]. For cystosarcomas which have
already manifested metastases, there is no sufficient treat-
ment available for a successful control of the disease [26].
The role of chemotherapy and radiotherapy remains
uncertain [27-30]. Today, however, the studies upon
estrogen and progesterone receptors in these tumors seem
to provide hopeful results, useful for the hormonal man-
agement of CP [30,31].
Conclusion
Cystosarcoma phylloides is a rare neoplastic condition of
the breast, which belongs to the non-epithelial tumors.
The classification by authors into benign and malignant is
not particularly successful, because the natural history of
the tumor is not always related to its histological image.
Its equivocal biological behavior may affect the patients'
prognosis and survival, and thus it remains an unsolved
puzzle, which evolving studies will try to clarify in the
future.
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